Juvenile Dermatomyositis: Clinical Trials

2 trials for Juvenile Dermatomyositis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 2
Phase 21Recruiting 1

Follow Juvenile Dermatomyositis: new trials by email Literature Review of Juvenile Dermatomyositis trials Research Report on Juvenile Dermatomyositis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Descartes-08 - Childhood-onset Systemic Lupus Erythematous, ANCA-Associated Vasculitis (AAV)
Phase 1 / Phase 2RecruitingCartesian Therapeutics502026-01-142026-07-27
Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis
CD19-targetd CAR-T - Juvenile Dermatomyositis
Phase 1RecruitingChongqing Precision Biotech Co., Ltd102024-07-022024-08-26

Narrower conditions

Dermatomyositis (2)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)

Broader conditions

Connective Tissue Diseases (2)  ·  Muscular Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Myositis (2)  ·  Nervous System Diseases (2)  ·  Neuromuscular Diseases (2)  ·  Polymyositis (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Autoimmune Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Immune System Diseases (1)  ·  Skin Diseases, Vascular (1)  ·  Systemic Vasculitis (1)  ·  Vascular Diseases (1)

Sponsors

Cartesian Therapeutics (1)  ·  Chongqing Precision Biotech Co., Ltd (1)

Countries

China (1)  ·  United States (1)

Top investigators

Meiping Lu, M.D (1)